Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000071.xml
Download PDF
Semin Neurol 2003; 23(3): 307-314
DOI: 10.1055/s-2003-814742
DOI: 10.1055/s-2003-814742
Sleep Disorders
Further Information
Publication History
Publication Date:
14 January 2004 (online)
ABSTRACT
Patients with sleep disorders present with a variety of complaints including excessive daytime sleepiness, daytime spells, inability to sleep, uncomfortable sensation in the extremities, and unusual night time behaviors. This article provides eight vignettes on patients with sleep disorders including narcolepsy, idiopathic hypersomnia, obstructive sleep apnea, restless legs syndrome, and rapid eye movement behavior disorder. The discussion provides data regarding the epidemiology, pathophysiology, and diagnostic approach for these conditions. The various treatment options for these sleep disorders are also identified.
KEYWORDS
Narcolepsy - cataplexy - restless legs - rapid eye movement behavior disorder
REFERENCES
- 1 Silber M, Krahn L, Olson E, Pankratz V. Epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep . 2001; 24 A98
- 2 Krahn L, Boeve B, Olson E, Herold D, Silber M. A standardized test for cataplexy. Sleep Med . 2000; 1 125-130
- 3 Broughton R, Guberman A, Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia . 1984; 25 423-433
- 4 Silber M, Krahn L, Olson E, Pankratz V. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep . 2002; 25 197-202
- 5 Mignot E, Hayduk R, Black J, Grumet F, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep . 1997; 20 1012-1020
- 6 Chervin R, Dillon J, Bassetti C, Ganoczy D, Pituch K. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep . 1997; 20 1185-1192
- 7 Krahn L, Hansen M, Shepard J. Pseudocataplexy. Psychosomatics . 2001; 42 356-358
- 8 Krahn L, Black J, Silber M. Narcolepsy: new understanding of irresistible sleep. Mayo Clin Proc . 2001; 76 185-194
- 9 Overeem S, Mignot E, Gert van Dijk J, Lammers G. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol . 2001; 18 78-105
- 10 Black J, Krahn L, Silber M. A pilot study of serologic markers of autoimmunity in patients with narcolepsy. Sleep . 2001; 24 A318-A319
- 11 Thannickal T, Moore R, Nienhuis R. et al . Reduced number of hypocretin neurons in human narcolepsy. Neuron . 2000; 27 469-474
- 12 Nishino S, Ripley B, Overeem S, Lammers G, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy (letter). Lancet . 2000; 355 39-40
- 13 Schuld A, Blum W, Pollmacher T. Low CSF hypocretin (orexin) and altered energy metabolism in human narcolepsy. Ann Neurol . 2002; 51 660-661
- 14 Mignot E, Lammers G, Ripley B. et al . The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol . 2002; 59 1553-1562
- 15 Smart D, Jerman J. The physiology and pharmacology of the orexins. Pharmacol Ther . 2002; 94 51-61
- 16 US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol . 1998; 43 88-97
- 17 Scharf M, Lai A, Branigan B, Stover R, Berkowitz D. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep . 1998; 21 507-514
- 18 Zyrem Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep . 2002; 25 42-49
- 19 Mitler M, Shafor R, Hajdukovich R, Timms R, Browman C. Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline. Sleep . 1986; 9 260-264
- 20 Billiard M, Merle C, Carlander B, Ondze B, Alvarez D, Besset A. Idiopathic hypersomnia. Psychiatry Clin Neurosci . 1998; 52 125-129
- 21 Bassetti C, Aldrich M. Idiopathic hypersomnia: a series of 42 patients. Brain . 1997; 120 1423-1435
- 22 Kanbayashi T, Inque Y, Chiba S. et al . CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res . 2002; 11 91-93
- 23 Walker R. Long-term health consequences of mild to moderate obstructive sleep apnea. Arch Otolaryngol Head Neck Surg . 2001; 127 1397-1400
- 24 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med . 1993; 328 1230-1235
- 25 Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med . 2002; 165 1217-1239
- 26 Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med . 1995; 1 482-487
- 27 Rama A, Tekwani S, Kushida C. Sites of obstruction in obstructive sleep apnea. Chest . 2002; 122 1139-1147
- 28 Dart R, Gregoire J, Gutterman D, Woolf S. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest . 2003; 123 244-260
- 29 Bananian S, Lehrman S, Maguire G. Cardiovascular consequences of sleep-related breathing disorders. Heart Dis . 2002; 4 296-305
- 30 Loh N, Dinner D, Foldvary N, Skobieranda F, Yew W. Do patients with obstructive sleep apnea wake up with headaches?. Arch Intern Med . 1999; 159 1765-1768
- 31 Dodick D, Eross E, Parish J. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. ; 34 282-292
- 32 Berry R, Parish J, Hartse K. The use of auto-titrating continuous positive airway pressure for the treatment of adult obstructive sleep apnea: an American Academy of Sleep Medicine review. Sleep . 2002; 25 148-173
- 33 Sullivan C, Grunstein R. Continuous positive airway pressure in sleep-disordered breathing. In: Kryger M, Roth T, Dement W, eds. Principles and Practice of Sleep Medicine 2nd ed. Philadelphia: WB Saunders 1994: 694
MissingFormLabel
- 34 Clark G, Blumenfeld I, Yoffe N, Peled E, Lavie P. A crossover study comparing the efficiency of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. Chest . 1996; 109 1477-1483
- 35
Flemons W.
Obstructive sleep apnea.
N Engl J Med .
2002;
347
498-504
MissingFormLabel
- 36 Lojander P, Maasilta P, Partinen M, Brander P, Salmi T, Lehtonen H. Nasal-CPAP and conservative management for treatment of obstructive sleep apnea syndrome: a randomized study. Chest . 1996; 110 114-119
- 37 Littner M, Kushida C, Hartse K. et al . Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. Sleep . 2001; 24 603-619
- 38 Berry R, Deas M, Light R. Effect of ethanol on the efficacy of nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest . 1991; 99 339-341
- 39 Dolly F, Block A. Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med . 1982; 73 239-243
- 40 Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients with new standard criteria. Move Disord . 1997; 12 61-65
- 41 Chaudhuri K, Appiah-Kubi L, Trenkwalder C. Restless legs syndrome. J Neurol Neurosurg Psychiatry . 2001; 71 143-146
- 42 Nicolas A, Michaud M, Lavigne G, Montplaisir J. The influence of sex, age and sleep/wake state on characteristics of periodic leg movements in restless legs syndrome patients. J Clin Neurophysiol . 1999; 110 1168-1174
- 43 Phillips B, Young T, Finn L, Asher K, Hening W, Purvis C. Epidemiology of restless legs syndrome in adults. Arch Intern Med . 2000; 160 2137-2141
- 44 Ohayon M, Roth T. Prevalence of restless legs syndrome and periodic movement disorder in the general population. J Psychosom Res . 2002; 53 547-554
- 45 Desautels A, Turecki G, Montplaisir J, Sequeira A, Verner A, Rouleau G. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet . 2001; 69 1266-1270
- 46 Bonati M, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain . 2003; 126 1485-1492
- 47 Winkelmann J, Chertow G, Lazarus J. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis . 1996; 28 372-378
- 48 Takaki J, Nishi T, Nangaku M. et al . Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis . 2003; 41 833-839
- 49 Ruottinen H, Partinen M, Hublin C. et al . An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology . 2000; 54 502-504
- 50 Earley C, Allen R, Beard J, Connor J. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res . 2000; 62 623-628
- 51 Allen R, Earley C. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol . 2001; 18 128-147
- 52 Comella C. Restless legs syndrome: treatment with dopaminergic agents. Neurology . 2002; 58 S87-S92
- 53 Saletu M, Anderer P, Saletu-Zyhlarz G, Hauer C, Saletu B. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome. Eur Arch Psychiatry Clin Neurosci . 2002; 252 185-194
- 54 Pritchett A, Morrison J, Edwards W D, Schaff H, Connolly H, Espinosa R. Valvular heart disease in patients taking pergolide. Mayo Clin Proc . 2002; 77 1280-1286
- 55 Garcia-Borreguero D, Larrosa O, de la Llave Y, Verger K, Masramon X, Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology . 2002; 59 1573-1579
- 56 Walters A, Winkelmann J, Trenkwalder C. et al . Long-term follow-up on restless legs syndrome patients treated with opioids. Move Disord . 2001; 16 1105-1109
- 57 Davis B, Rajput A, Rajput M, Aul E, Eichhorn G. A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome. Eur Neurol . 2000; 43 70-75
- 58 Schenck C, Bundlie S, Ettinger M, Mahowald M. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep . 1986; 9 293-308
- 59 Schenck C, Hurwitz T, Mahowald M. Symposium: normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature. Sleep . 1993; 2 224-231
- 60
Olson E, Boeve B, Silber M.
Rapid eye movement sleep behavior disorder: demographic, clinical and laboratory findings
in 93 cases.
Brain .
2000;
123
331-339
MissingFormLabel
- 61 Schenck C, Mahowald M, Kim S, O'Connor K, Hurwitz T. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep . 1992; 15 226-235
- 62 Comella C, Nardine T, Diedrich N, Stebbins G. Sleep-related violence, injuries and REM behavior disorder in Parkinson's disease. Neurology . 1998; 51 526-529
- 63 Plazzi G, Corsini R, Provini F. et al . REM behavior disorder in multiple system atrophy. Neurology . 1997; 48 1094-1097
- 64 Boeve B, Silber M, Ferman T, Lucas J, Parisi J. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Move Disord . 2001; 16 622-630
- 65 Schenck C, Mahowald M. Long-term, nightly benzodiazepine treatment of injurious parasomnias and other disorders of disrupted nocturnal sleep in 170 adults. Am J Med . 1996; 100 333-337